closeCreated with sketchtool.
Show all results

Consolidated Statement of Changes in Net Equity

For details see Note (36) ‟Equity”.

35.5 KB EXCEL

Equity capital Retained earnings Gains/losses recognized in equity
€ million General partner’s equity Merck KGaA, Darmstadt, Germany Subscribed capital Merck KGaA, Darmstadt, Germany Capital reserves (share premium) Merck KGaA, Darmstadt, Germany Retained earnings/net retained profit Remeasurement of defined benefit plans Fair value reserve for equity instruments Available-for-sale financial assets1 Fair value reserve for debt instruments1 Cash flow hedge reserve Cost of hedging reserve1 Currency translation difference Equity attributable to Merck KGaA, Darmstadt, Germany Non-controlling interests Total equity
January 1, 2017 (as reported) 397 168 3,814 8,049 – 1,501 24 – 191 3,229 13,989 61 14,050
Adjustment due to mandatory
retrospective adoption of IFRS 91
– 3 3
January 1, 2017 (restated) 397 168 3,814 8,046 – 1,501 24 – 191 3 3,229 13,989 61 14,050
Profit after tax2 2,605 2,605 10 2,615
Other comprehensive income2 142 7 69 – 4 – 2,057 – 1,843 – 4 – 1,847
Comprehensive income 2,605 142 7 69 – 4 – 2,057 761 6 767
Dividend payments – 155 – 155 – 4 – 159
Profit transfer to/from E. Merck KG, Darmstadt, Germany including changes in reserves – 593 – 593 – 593
Transactions with no change of control
Changes in scope of consolidation/Other 1 1 1
December 31, 20172 397 168 3,814 9,903 – 1,358 31 – 121 – 1 1,171 14,003 63 14,066
 
January 1, 2018 397 168 3,814 9,903 – 1,358 31 – 121 – 1 1,171 14,003 63 14,066
Adjustment on initial application of IFRS 91 23 – 6 – 31 – 1 – 15 – 15
Adjustment on initial application of IFRS 151
Adjustment on application of IAS 291 4 1 4 4
January 1, 2018 (restated) 397 168 3,814 9,930 – 1,358 – 6 – 1 – 121 – 1 1,171 13,992 63 14,055
Profit after tax 3,374 3,374 22 3,396
Other comprehensive income – 41 29 – 7 – 32 619 569 – 1 568
Comprehensive income 3,374 – 41 29 – 7 – 32 619 3,943 22 3,964
Dividend payments – 162 – 162 – 13 – 175
Profit transfer to/from E. Merck KG, Darmstadt, Germany
including changes in reserves
– 515 – 515 – 515
Transactions with no change of control – 55 – 55 55
Changes in scope of consolidation/Other – 46 59 – 16 – 3 – 93 – 96
December 31, 2018 397 168 3,814 12,525 – 1,340 7 – 1 – 128 – 33 1,790 17,200 33 17,233
1
See (49) ‟Effects from new accounting standards and other presentation and measurement changes” ‟Effects from new accounting standards and other presentation and measurement changes”.
2
Previous year’s figures have been adjusted, see Note (49) ‟Effects from new accounting standards and other presentation and measurement changes”.